Welcome : Guest

Provexis Plc (UK) - Facts, Figures and Analytical Insights


This report presents quick facts about Provexis Plc, which is principally involved in Developing Anti-Thrombotic Technology. Illustrated with 6 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-41348
Price: $300
Company Type: Public
Pages: 8
Date: February 2016
Market Data Tables: 6

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Anti-Clotting Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Enoxaparin, Fondaparinux, Heparin and Xa inhibitors......3
Anticoagulation Therapy......4
Table 2: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......4
Table 3: Anticoagulation Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......5
Table 4: Anticoagulation Therapy by Segment Worldwide (2014) - Percentage Market Share Breakdown by Value for Acute Coronary Syndrome and Myocardial Infarction, Prevention of Venous Thromboembolism, Stroke Prevention in Atrial Fibrillation, Venous Thromboembolism Treatment and Other Primary Prevention......6
Table 5: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......7
Table 6: Market Shares of Leading Anti-Clotting Brands in the US (2015) – Percentage Market Share Breakdown by Value for Arixtra, Enoxaparin, Fonda. - APO, Heparin, Lovenox, and Xarelto......8